Market revenue in 2023 | USD 300.4 million |
Market revenue in 2030 | USD 327.6 million |
Growth rate | 1.2% (CAGR from 2023 to 2030) |
Largest segment | Immunoturbidimetric assay |
Fastest growing segment | Chemiluminescence Immunoassay |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Immunoturbidimetric Assay, Chemiluminescence Immunoassay, Other Assay Types, ELISA |
Key market players worldwide | Thermo Fisher Scientific Inc, Roche Holding AG ADR, Danaher Corp, Quest Diagnostics Inc, Siemens Healthineers AG ADR, Abbott Laboratories, Merck KGaA, Zoetis Inc Class A, QuidelOrtho Corp, Horiba Ltd, Getein Biotech, Boditech Med, Randox, Aidian |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to c-reactive protein testing market will help companies and investors design strategic landscapes.
Immunoturbidimetric assay was the largest segment with a revenue share of 48.5% in 2023. Horizon Databook has segmented the UK c-reactive protein testing market based on immunoturbidimetric assay, chemiluminescence immunoassay, other assay types, elisa covering the revenue growth of each sub-segment from 2018 to 2030.
Support offered by organizations such as National Institute for Health & Excellence (NICE) for promoting the development of point-of-care CRP testing devices in the region also boosts the market growth.
The organization also recommended the use of POC CRP testing devices by Alere & Orion Diagnostica Oy in primary care settings. Moreover, the study on PoC CRP for diagnosis of lower respiratory tract infections in primary care units of NHS England are expected to increase penetration of CRP tests within the country.
This study was conducted in 2016 to estimate barriers & facilitators for the adoption of POC CRP testing in primary healthcare centers. In UK, the primary issue appears to be a lack of funding and reimbursement for doing the test.
Horizon Databook provides a detailed overview of country-level data and insights on the UK c-reactive protein testing market , including forecasts for subscribers. This country databook contains high-level insights into UK c-reactive protein testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account